META BIOMED CO., LTD. Meta Biomed Co., Ltd. Stock
Equities
A059210
KR7059210005
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,080 KRW | +3.04% |
|
+27.96% | +16.51% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 68.94B 50.47M | Sales 2023 | 83.1B 60.83M | Capitalization | 99.72B 72.99M |
|---|---|---|---|---|---|
| Net income 2022 | 2.63B 1.92M | Net income 2023 | 10.08B 7.38M | EV / Sales 2022 | 1.13 x |
| Net Debt 2022 | 24.93B 18.25M | Net Debt 2023 | 27.64B 20.23M | EV / Sales 2023 | 1.53 x |
| P/E ratio 2022 |
20.1
x | P/E ratio 2023 |
9.89
x | Employees | 276 |
| Yield 2022 |
0.87% | Yield 2023 |
0.46% | Free-Float | 71.81% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.04% | ||
| 1 week | +27.96% | ||
| Current month | +19.95% | ||
| 1 month | +22.71% | ||
| 3 months | +6.50% | ||
| 6 months | +12.64% | ||
| Current year | +16.51% |
1 week
3 970.00
5 240.00
1 month
3 890.005 240.00
Current year
3 815.005 570.00
1 year
3 345.005 570.00
3 years
2 050.005 570.00
5 years
1 485.005 570.00
10 years
1 485.009 080.00
| Managers | Title | Age | Since |
|---|---|---|---|
Seok-Song Oh
FOU | Founder | 69 | 90-02-28 |
Yeon-Choon Yoo
BRD | Director/Board Member | 57 | - |
Seong-Il Cho
AUD | Comptroller/Controller/Auditor | 70 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Seok-Song Oh
FOU | Founder | 69 | 90-02-28 |
Yeon-Choon Yoo
BRD | Director/Board Member | 57 | - |
Yeong-Ha Kim
BRD | Director/Board Member | 78 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 5,080 | +3.04% | 1,388,040 |
| 24-05-20 | 4,930 | +0.31% | 1,030,383 |
| 24-05-17 | 4,915 | +2.29% | 5,736,848 |
| 24-05-16 | 4,805 | +21.03% | 4,826,922 |
| 24-05-14 | 3,970 | -0.38% | 258,959 |
End-of-day quote Korea S.E., May 20, 2024
More quotes
Meta Biomed Co., Ltd. is a Korea-based company engaged in the manufacture of medical materials and equipment for biotechnology and dental areas. The Company mainly operates its business through three divisions: suture material division, dental division and bone material division. Its suture material division provides suture materials, such as polyglycolic acid (PGA) synthetic absorbable braids, polyglycolic acid-co-lactic acid (PGLA) absorbable braids, polydioxanone (PDO) synthetic absorbable monofilaments, polyglycolide-co-epsilon-caprolactone (PGCL) synthetic absorbable monofilaments and others. Its dental division provides dental materials and equipment, such as gutta percha cordless obturation systems, electronic apex locators, taper points, root canal sealers, root canal filling materials and others. Its bone materials division provides bone graft substitutes. It also distributes dental-related products.
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.51% | 85.23M | |
| -6.46% | 179B | |
| +3.39% | 113B | |
| -3.68% | 67.88B | |
| +5.44% | 52.03B | |
| +5.70% | 43.3B | |
| +4.03% | 41.79B | |
| +25.42% | 32.49B | |
| +14.00% | 25.65B | |
| -4.29% | 24.55B |
- Stock Market
- Equities
- A059210 Stock